| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired spherocytic like anemia combined with ineffective erythropoiesis sustains anemia in patients with chronic hepatitis C infection receiving telaprevir or boceprevir-based triple therapy
|
Lupo, F.
|
|
2015
|
47 |
S1 |
p. e15-
1 p.
|
artikel
|
| 2 |
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography
|
Filomia, R.
|
|
2015
|
47 |
S1 |
p. e17-
1 p.
|
artikel
|
| 3 |
Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucleot(s)ide analogues treatment: HERMES Study Interim Analysis
|
Lampertico, P.
|
|
2015
|
47 |
S1 |
p. e28-
1 p.
|
artikel
|
| 4 |
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice
|
Piai, G.
|
|
2015
|
47 |
S1 |
p. e25-
1 p.
|
artikel
|
| 5 |
Adherence to EASL-EORTC clinical guidelines for the management of hepatocellular carcinoma in field practice: Results from the ITALICA database
|
Sacco, R.
|
|
2015
|
47 |
S1 |
p. e36-
1 p.
|
artikel
|
| 6 |
Adrenergic hyperfunction is a key trigger of solute-free water retention in ascitic cirrhosis: vasopressin (ADH) is not the only agent to blame
|
Sansoè, G.
|
|
2015
|
47 |
S1 |
p. e19-
1 p.
|
artikel
|
| 7 |
A high HBsAg genetic complexity can influence HBV immunogenicity in the setting of acute infection
|
Battisti, A.
|
|
2015
|
47 |
S1 |
p. e50-
1 p.
|
artikel
|
| 8 |
A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro
|
Colagrossi, L.
|
|
2015
|
47 |
S1 |
p. e11-e12
nvt p.
|
artikel
|
| 9 |
A.I.S.F. 2015: Abstracts evaluation procedure
|
|
|
2015
|
47 |
S1 |
p. e67-
1 p.
|
artikel
|
| 10 |
Analysis of the association of pediatric NAFLD with two SNPs of genes encoding for fibroblast growth factors 19 and 21 receptor system
|
Crudele,
|
|
2015
|
47 |
S1 |
p. e34-
1 p.
|
artikel
|
| 11 |
A NOVEL ROLE FOR THE KYNURENINE PATHWAY IN EXPERIMENTAL STEATOHEPATITIS
|
Vivoli, E.
|
|
2015
|
47 |
S1 |
p. e21-
1 p.
|
artikel
|
| 12 |
Anti capsid drugs HAP12 and AT130 target HBV core protein nuclear functions
|
Belloni, L.
|
|
2015
|
47 |
S1 |
p. e10-
1 p.
|
artikel
|
| 13 |
Anticoagulation does not increase portal hypertension related bleeding, but exposes patients with cirrhosis to a high risk of minor hemorrhages: Results from a comparative cohort study
|
La Mura, V.
|
|
2015
|
47 |
S1 |
p. e18-
1 p.
|
artikel
|
| 14 |
AntiHBs is a useful tool for searching the risk of hepatitis B reativation: a meta-analysis of observational studies in patients with lymphoma
|
Fiore, M.
|
|
2015
|
47 |
S1 |
p. e59-e60
nvt p.
|
artikel
|
| 15 |
Antiviral therapy with sofosbuvir plus ribavirin for the treatment of severe HCV recurrence after liver transplantation: preliminary data from a single-centre experience
|
Arese, D.
|
|
2015
|
47 |
S1 |
p. e26-
1 p.
|
artikel
|
| 16 |
Assessment of free light chains in HCV positive patients with mixed cryoglobulinemia vasculitis undergoing rituximab treatment
|
Basile, U.
|
|
2015
|
47 |
S1 |
p. e27-
1 p.
|
artikel
|
| 17 |
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION
|
Coppola, N.
|
|
2015
|
47 |
S1 |
p. e61-e62
nvt p.
|
artikel
|
| 18 |
Autofluorescence detection of liver oxidative damage products
|
Croce, A.C.
|
|
2015
|
47 |
S1 |
p. e51-e52
nvt p.
|
artikel
|
| 19 |
Boceprevir or telaprevir plus peginterferon/ribavirin in HCV chronic infection: the real-life experience of the Italian Association of hospital hepatologists (CLEO)
|
|
|
2015
|
47 |
S1 |
p. e41-
1 p.
|
artikel
|
| 20 |
Can Hepatic Resection Provide A Long-Term Cure to Patients with Intrahepatic Cholangiocarcinoma?
|
Spolverato, G.
|
|
2015
|
47 |
S1 |
p. e51-
1 p.
|
artikel
|
| 21 |
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon?
|
Ciaccio, A.
|
|
2015
|
47 |
S1 |
p. e58-
1 p.
|
artikel
|
| 22 |
Chronic hepatitis B treatment individualization by means of serum HBsAg and MiR-B-Index kinetics
|
Cavallone, D.
|
|
2015
|
47 |
S1 |
p. e30-
1 p.
|
artikel
|
| 23 |
Chronic Intermittent Hypoxia is associated with Liver Damage and Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease
|
Petta, S.
|
|
2015
|
47 |
S1 |
p. e48-e49
nvt p.
|
artikel
|
| 24 |
Chronic particulate matter exposition and western diet induce the progression from steatosis to steatohepatitis
|
Tarocchi, M.
|
|
2015
|
47 |
S1 |
p. e19-e20
nvt p.
|
artikel
|
| 25 |
Clinical evaluation of circulating microRNAs as potential biomarkers of hepatocellular carcinoma in patients with chronic HBV infection
|
Caviglia, G.P.
|
|
2015
|
47 |
S1 |
p. e47-
1 p.
|
artikel
|
| 26 |
Clinically guided adjustment of sorafenib daily dose is advisable for cirrhotics patients with hepatocellular carcinoma (HCC)
|
Gallusi, G.
|
|
2015
|
47 |
S1 |
p. e34-
1 p.
|
artikel
|
| 27 |
Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study
|
Piscaglia, F.
|
|
2015
|
47 |
S1 |
p. e36-e37
nvt p.
|
artikel
|
| 28 |
Clinical presentation, treatment and outcome of alcohol- and hepatitis C virus- related hepatocellular carcinoma in the new century: comparison before and after adjustment with propensity score analysis
|
Bucci, L.
|
|
2015
|
47 |
S1 |
p. e54-
1 p.
|
artikel
|
| 29 |
Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors
|
Armenia, D.
|
|
2015
|
47 |
S1 |
p. e48-
1 p.
|
artikel
|
| 30 |
Complications after percutaneous radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) in cirrhosis: 20 years experience in a single center
|
Giorgio, A.
|
|
2015
|
47 |
S1 |
p. e21-e22
nvt p.
|
artikel
|
| 31 |
Coronary microvascular dysfunction in patients with primary biliary cirrhosis without metabolic syndrome: a hint for their increased cardiovascular risk
|
Cazzagon, N.
|
|
2015
|
47 |
S1 |
p. e45-
1 p.
|
artikel
|
| 32 |
Correlation between NK cells and response to triple HCV-therapy with BOC/TVR
|
Marenco, S.
|
|
2015
|
47 |
S1 |
p. e66-
1 p.
|
artikel
|
| 33 |
Cost-effectiveness of pre-transplant Sofosbuvir to prevent recurrence of HCV infection after liver transplantation
|
Vitale, A.
|
|
2015
|
47 |
S1 |
p. e7-
1 p.
|
artikel
|
| 34 |
D-dimer and fibrinolytic activity in patients with decompensated liver cirrhosis
|
Romanelli, R.G.
|
|
2015
|
47 |
S1 |
p. e33-
1 p.
|
artikel
|
| 35 |
Deep-sequencing analysis demonstrates the persistence of pre-transplant HCV dominant variants within a more homogeneous quasispecies after liver transplantation (LT) in cholestatic hepatitis C patients
|
Gambato, M.
|
|
2015
|
47 |
S1 |
p. e44-
1 p.
|
artikel
|
| 36 |
Diagnostic accuracy of liver and spleen stiffness measurement for portal hypertension using bidimensional shear weave elastography
|
Stefanescu, H.
|
|
2015
|
47 |
S1 |
p. e18-
1 p.
|
artikel
|
| 37 |
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy
|
Sukowati, C. H.C.
|
|
2015
|
47 |
S1 |
p. e56-
1 p.
|
artikel
|
| 38 |
“EARLY” SUBCLINICAL LEFT VENTRICULAR DISFUNCTION IN PATIENTS WITH HEPATITIS C VIRUS INFECTION
|
Rocco, A.
|
|
2015
|
47 |
S1 |
p. e60-
1 p.
|
artikel
|
| 39 |
Editorial board
|
|
|
2015
|
47 |
S1 |
p. i-
1 p.
|
artikel
|
| 40 |
Effectiveness of Adalibumab for patients with primary sclerosing cholangitis associated with inflammatory bowel disease
|
Franceschet, I.
|
|
2015
|
47 |
S1 |
p. e41-
1 p.
|
artikel
|
| 41 |
Efficacy of sorafenib in patients with intermediate-stage hepatocellular carcinoma: results from the ITA.LI.CA. database
|
Sacco, R.
|
|
2015
|
47 |
S1 |
p. e66-
1 p.
|
artikel
|
| 42 |
ELF TEST IS A RELIABLE TOOL FOR NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
|
Miele, L.
|
|
2015
|
47 |
S1 |
p. e58-
1 p.
|
artikel
|
| 43 |
ENOS dysfunction in Steatosis and Steatohepatitis
|
Masarone, M.
|
|
2015
|
47 |
S1 |
p. e55-
1 p.
|
artikel
|
| 44 |
eNOS polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib
|
Gardini, A. Casadei
|
|
2015
|
47 |
S1 |
p. e8-
1 p.
|
artikel
|
| 45 |
17β-Estradiol inhibits hepatitis C (HCV) infection via binding to its receptor
|
Giarda, P.
|
|
2015
|
47 |
S1 |
p. e14-e15
nvt p.
|
artikel
|
| 46 |
Fas-Ligand involvement in end stage liver disease
|
Trombetta, E.
|
|
2015
|
47 |
S1 |
p. e37-
1 p.
|
artikel
|
| 47 |
First steps towards understanding the dynamic evolution of gut microbiota in different stages of liver disease
|
Ponziani, F.R.
|
|
2015
|
47 |
S1 |
p. e53-
1 p.
|
artikel
|
| 48 |
Guanfacine (specific alpha-2A adrenoceptor agonist) restores natriuresis in experimental cirrhotic ascites resistant to clonidine and standard diuretics
|
Sansoè, G.
|
|
2015
|
47 |
S1 |
p. e1-e2
nvt p.
|
artikel
|
| 49 |
Gut–liver axis derangement due to lack of inflammasome activity leads to visceral obesity and NASH development
|
Agostinelli, L.
|
|
2015
|
47 |
S1 |
p. e4-
1 p.
|
artikel
|
| 50 |
HBsAg loss is enough to discontinue long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients in real practice?
|
Fasano, M.
|
|
2015
|
47 |
S1 |
p. e12-
1 p.
|
artikel
|
| 51 |
HBsAg NEGATIVE ANTI-HBc POSITIVE SEROLOGY INCREASES THE RISK OF HCC IN CHRONIC HEPATITIS PATIENTS: A META-ANALYSIS
|
Coppola, N.
|
|
2015
|
47 |
S1 |
p. e61-
1 p.
|
artikel
|
| 52 |
HBV genetic compartimentalization, variability and molecular correlates of histologic and immunohistochemical aspects in liver tissue: implications for the clinical management of patients with chronic hepatitis B
|
Minosse, C.
|
|
2015
|
47 |
S1 |
p. e62-e63
nvt p.
|
artikel
|
| 53 |
HBx–DLEU2 lncRNA complex affects transcription of new target promoters
|
Guerrieri, F.
|
|
2015
|
47 |
S1 |
p. e30-
1 p.
|
artikel
|
| 54 |
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma
|
Cucchetti, A.
|
|
2015
|
47 |
S1 |
p. e38-
1 p.
|
artikel
|
| 55 |
Hepatitis Delta prevalence and clinical expression in an immigrant population in Italy
|
Colucci, G.
|
|
2015
|
47 |
S1 |
p. e39-
1 p.
|
artikel
|
| 56 |
Hepcidin resistance in dysmetabolic iron overload
|
Rametta, R.
|
|
2015
|
47 |
S1 |
p. e16-
1 p.
|
artikel
|
| 57 |
HIF2α neddylation as a selective SerpinB3-dependent mechanism leading to its increased stabilization and nuclear translocation in liver cancer cells
|
Cannito, S.
|
|
2015
|
47 |
S1 |
p. e32-
1 p.
|
artikel
|
| 58 |
High capability of contrast enhanced ultrasound in defining a rapid diagnostic and therapeutic work-up for nodules <2cm in cirrhotics during surveillance
|
Giorgio, A.
|
|
2015
|
47 |
S1 |
p. e12-e13
nvt p.
|
artikel
|
| 59 |
HLA DPB1 rs9277535 polymorphism strongly predicts HBsAg clearance in interferon treated genotype D HBeAg-negative patients with chronic hepatitis B
|
Lampertico, P.
|
|
2015
|
47 |
S1 |
p. e28-
1 p.
|
artikel
|
| 60 |
IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients
|
Galmozzi, E.
|
|
2015
|
47 |
S1 |
p. e49-
1 p.
|
artikel
|
| 61 |
Impact of anticoagulation on the evolution of portal vein thrombosis in cirrhosis: a retrospective analysis
|
Pettinari, I.
|
|
2015
|
47 |
S1 |
p. e59-
1 p.
|
artikel
|
| 62 |
Impact of rifaximin in the prevention of bacterial infections in cirrhosis
|
Mariani, M.
|
|
2015
|
47 |
S1 |
p. e53-e54
nvt p.
|
artikel
|
| 63 |
Impulsional, point and bidimensional share wave elastometry for portal hypertension: same stiffness threshold?
|
Stefanescu, H.
|
|
2015
|
47 |
S1 |
p. e31-
1 p.
|
artikel
|
| 64 |
Incidence and risk factors of hepatocellular carcinoma in untreated subjects with chronic hepatitis B virus infection: a systematic review and meta-analysis
|
Raffetti, E.
|
|
2015
|
47 |
S1 |
p. e25-
1 p.
|
artikel
|
| 65 |
Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic fatty Liver Disease
|
Vanni, E.
|
|
2015
|
47 |
S1 |
p. e20-
1 p.
|
artikel
|
| 66 |
JNK signaling activated by Platelet-Derived Growth Factor D (PDGF-D) stimulates secretion of Vascular Endothelial Growth Factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastatization in cholangiocarcinoma
|
Cadamuro, M.
|
|
2015
|
47 |
S1 |
p. e22-e23
nvt p.
|
artikel
|
| 67 |
Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma
|
Viganò, M.
|
|
2015
|
47 |
S1 |
p. e62-
1 p.
|
artikel
|
| 68 |
LITAF role in in vivo hepatocyte proliferation and in hepatocarcinoma cells
|
Panera, N.
|
|
2015
|
47 |
S1 |
p. e64-
1 p.
|
artikel
|
| 69 |
Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease
|
Rosso, C.
|
|
2015
|
47 |
S1 |
p. e5-
1 p.
|
artikel
|
| 70 |
Liver transplantation (OLT) and cardiovascular risk: assessment of early atherosclerotic damage and metabolic disorders in patients undergoing liver transplantation
|
Pisano, G.
|
|
2015
|
47 |
S1 |
p. e56-
1 p.
|
artikel
|
| 71 |
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: The interim analysis of the ANSWER study
|
Bernardi, M.
|
|
2015
|
47 |
S1 |
p. e6-
1 p.
|
artikel
|
| 72 |
Metabolic Syndrome after liver transplantation: have risk factors changed over time?
|
Vanni, E.
|
|
2015
|
47 |
S1 |
p. e46-
1 p.
|
artikel
|
| 73 |
Metformin targets a new EZH2-phosphoSTAT3-miRNAs pathway to inhibit lipid droplets accumulation and intracellular inflammation
|
Pediconi, N.
|
|
2015
|
47 |
S1 |
p. e3-
1 p.
|
artikel
|
| 74 |
Mir-106b for HCC patient management after therapy
|
Pascut, D.
|
|
2015
|
47 |
S1 |
p. e24-
1 p.
|
artikel
|
| 75 |
Mir-17/92 expression pattern: A molecular signature of HCV-related mixed cryoglobulinemia
|
Piluso, A.
|
|
2015
|
47 |
S1 |
p. e13-
1 p.
|
artikel
|
| 76 |
Neutrophil function in patients with chronic hepatitis C (CHC) undergoing triple antiviral therapy (TT) with first and second generation protease inhibitors (PI)
|
Gambato, M.
|
|
2015
|
47 |
S1 |
p. e37-
1 p.
|
artikel
|
| 77 |
NLRP3 inflammasome increases hepatic fibrosis by inducing inflammatory signals in hepatic stellate cells
|
Rychlicki, C.
|
|
2015
|
47 |
S1 |
p. e20-
1 p.
|
artikel
|
| 78 |
Non-infectious co-morbidities in HIV patients co-infected with hepatitis viruses: an analysis from the CalabrHIV study group
|
Postorino, M.C.
|
|
2015
|
47 |
S1 |
p. e49-e50
nvt p.
|
artikel
|
| 79 |
Notch4 and MHC class II polymorphisms contribute to HCV-related benign and malignant lymphoproliferative diseases
|
Piluso, A.
|
|
2015
|
47 |
S1 |
p. e14-
1 p.
|
artikel
|
| 80 |
Obliterative portal venopathy in the absence of clinical portal hypertension: An unexplored planet
|
Guido, M.
|
|
2015
|
47 |
S1 |
p. e17-
1 p.
|
artikel
|
| 81 |
Oleuropein reduces inflammatory mediators and hepatic immune cells infiltration in a mouse model of NAFLD
|
Arciello, M.
|
|
2015
|
47 |
S1 |
p. e24-
1 p.
|
artikel
|
| 82 |
Omomyc against HCC: A Myc dominant interfering miniprotein to counteract tumor growth
|
Barbaro, B.
|
|
2015
|
47 |
S1 |
p. e3-
1 p.
|
artikel
|
| 83 |
Oral bacterial load in autoimmune liver diseases: possible role or coincidence?
|
Orrù, G.
|
|
2015
|
47 |
S1 |
p. e65-
1 p.
|
artikel
|
| 84 |
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study
|
Fabris, L.
|
|
2015
|
47 |
S1 |
p. e16-
1 p.
|
artikel
|
| 85 |
Overall survival in intermediate-stage hepatocellular carcinoma (HCC) patients after first transarterial chemoembolization (TACE): proposal of a new scoring system
|
Sacco, R.
|
|
2015
|
47 |
S1 |
p. e44-
1 p.
|
artikel
|
| 86 |
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD
|
Berardo, C.
|
|
2015
|
47 |
S1 |
p. e60-e61
nvt p.
|
artikel
|
| 87 |
PANTOPRAZOLE AND RABEPRAZOLE DO NOT IMPACT THE ACTIVITY OF CYTOCHROME P450 ASSESSED BY [13C]-AMINOPYRINE BREATH TEST IN PATIENTS WITH LIVER CIRRHOSIS
|
Rocco, A.
|
|
2015
|
47 |
S1 |
p. e63-
1 p.
|
artikel
|
| 88 |
Pathogenesis and clinical impact of relative adrenal insufficiency in hospitalized patients with acute decompensation of cirrhosis
|
Piano, S.
|
|
2015
|
47 |
S1 |
p. e7-
1 p.
|
artikel
|
| 89 |
Pharmacological inhibition of Sirt1 promotes apoptosis and senescence of hepatic stellate cells during liver injury
|
Tarocchi, M.
|
|
2015
|
47 |
S1 |
p. e22-
1 p.
|
artikel
|
| 90 |
PNPLA3 RS738409 I748M is associated with steatohepatitis in non obese subjects with hepatitis C
|
Petta, S.
|
|
2015
|
47 |
S1 |
p. e27-
1 p.
|
artikel
|
| 91 |
PNPLA3 variant is an independent predictor of severe steatosis in patients with cronic hepatitis C and HIV infection
|
Sagnelli, C.
|
|
2015
|
47 |
S1 |
p. e39-
1 p.
|
artikel
|
| 92 |
Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications
|
Morello, E.
|
|
2015
|
47 |
S1 |
p. e41-e42
nvt p.
|
artikel
|
| 93 |
Post-translational regulation of Polycystin 2 (PC2)expression as a novel mechanism of cholangiocyte reaction to biliary damage and repair
|
Spirli, C.
|
|
2015
|
47 |
S1 |
p. e26-
1 p.
|
artikel
|
| 94 |
PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
|
Pepe, V.
|
|
2015
|
47 |
S1 |
p. e52-
1 p.
|
artikel
|
| 95 |
Prevalence of hepatitis E in tertiary hospital centre in northern Italy
|
Zuccaro, V.
|
|
2015
|
47 |
S1 |
p. e53-
1 p.
|
artikel
|
| 96 |
Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience
|
Tosetti, G.
|
|
2015
|
47 |
S1 |
p. e10-
1 p.
|
artikel
|
| 97 |
Proactive dose adjustments are necessary in many ADV-experienced patients treated with TDF monotherapy for 5 years: A prospective cohort study in 320 patients
|
Lampertico, P.
|
|
2015
|
47 |
S1 |
p. e40-
1 p.
|
artikel
|
| 98 |
Reduction in sumoylation-dependent S100A4 nuclear import in cholangiocarcinoma by low dose paclitaxel halts tumor invasiveness and hematogenoous metastasization by down-modulating Rho-A and Cdc42 activities
|
Spagnuolo, G.
|
|
2015
|
47 |
S1 |
p. e21-
1 p.
|
artikel
|
| 99 |
Relationship between inflammatory mediators and frequency of the innate immune cells in patients with non-alcoholic fatty liver disease
|
Maggio, R.
|
|
2015
|
47 |
S1 |
p. e35-
1 p.
|
artikel
|
| 100 |
Residual HCV-RNA in liver explants from patients undergoing sofosbuvir and ribavirin treatment while awaiting liver transplantation is not associated with HCV relapse
|
Gambato, M.
|
|
2015
|
47 |
S1 |
p. e11-
1 p.
|
artikel
|
| 101 |
Risk factor for early kidney disease after liver transplantation and its impact on graft loss: Insights from the Liver Match cohort study
|
Corradini, S. Ginanni
|
|
2015
|
47 |
S1 |
p. e9-
1 p.
|
artikel
|
| 102 |
Role of Killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis
|
Littera, R.
|
|
2015
|
47 |
S1 |
p. e29-
1 p.
|
artikel
|
| 103 |
Sarcopenia at First Diagnosis Predicts a Reduced Survival in Patients Affected by Hepatocarcinoma
|
Antonelli, G.
|
|
2015
|
47 |
S1 |
p. e63-
1 p.
|
artikel
|
| 104 |
SARCOPENIA IS ASSOCIATED WITH A REDUCED SURVIVAL IN PATIENTS WITH HEPATOCARCINOMA UNDERGOING SORAFENIB TREATMENT
|
Gigante, E.
|
|
2015
|
47 |
S1 |
p. e65-
1 p.
|
artikel
|
| 105 |
Screening for the identification of autoimmune or lymphoproliferative onset in patients naïve to HCV antiviral treatment
|
Gulli, F.
|
|
2015
|
47 |
S1 |
p. e57-
1 p.
|
artikel
|
| 106 |
Selective LXRα intestinal activation reduces hepatic inflammation and fibrosis during the development of chronic liver injury
|
Pierantonelli, I.
|
|
2015
|
47 |
S1 |
p. e1-
1 p.
|
artikel
|
| 107 |
SerpinB3 and Yap interplay increases Myc oncogenic activity
|
Turato, C.
|
|
2015
|
47 |
S1 |
p. e31-
1 p.
|
artikel
|
| 108 |
SERUM ALPHA-FETOPROTEIN MODIFICATION (DELTA-AFP) IS A HIGHLY SPECIFIC TOOL TO SUSPECT HCC RECURRENCE AFTER LIVER TRANSPLANTATION
|
Ponziani, F.R.
|
|
2015
|
47 |
S1 |
p. e54-
1 p.
|
artikel
|
| 109 |
Serum SCCA-IgM can predict the development of HCC in patients with HCV-cirrhosis
|
Pieri, G.
|
|
2015
|
47 |
S1 |
p. e59-
1 p.
|
artikel
|
| 110 |
SHORT-TERM OUTCOME POST LIVER TRANSPLANTATION OF CIRRHOTIC LISTED OUTPATIENTS WITH FLUCTUATIONS OF EGFR
|
Fiacco, F.
|
|
2015
|
47 |
S1 |
p. e52-
1 p.
|
artikel
|
| 111 |
Slow achievement of HCV-RNA undetectability in cirrhotic patients treated with sofosbuvir+ribavirin: possible clinical implications in the liver transplant list management
|
Lenci, I.
|
|
2015
|
47 |
S1 |
p. e29-e30
nvt p.
|
artikel
|
| 112 |
Small Fibers Peripheral Neuropathy in Wilson's Disease: an In Vivo Documentation by Corneal Confocal Microscopy
|
Sturniolo, G.C.
|
|
2015
|
47 |
S1 |
p. e38-
1 p.
|
artikel
|
| 113 |
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis
|
Ciaccio, A.
|
|
2015
|
47 |
S1 |
p. e15-e16
nvt p.
|
artikel
|
| 114 |
Sofosbuvir plus ribavirin in HCV-infected cirrhotic patients awaiting liver transplantation: preliminary data from a single-centre experience
|
Martini, S.
|
|
2015
|
47 |
S1 |
p. e55-
1 p.
|
artikel
|
| 115 |
Stimulation of Nuclear Receptor PPAR-γ Limits NF-kB-dependent Inflammation in Cystic Fibrosis Biliary Epithelium
|
Scirpo, R.
|
|
2015
|
47 |
S1 |
p. e43-e44
nvt p.
|
artikel
|
| 116 |
Survival of patients with hepatocellular carcinoma (HCC) within the Bologna Liver Oncology Group: comparison with international guidelines
|
Terzi, E.
|
|
2015
|
47 |
S1 |
p. e33-
1 p.
|
artikel
|
| 117 |
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery
|
Patti, R.
|
|
2015
|
47 |
S1 |
p. e33-e34
nvt p.
|
artikel
|
| 118 |
The AAA+ ATPase Ruvbl1 coordinates liver metabolism and hepatocellular carcinoma progression
|
Mello, T.
|
|
2015
|
47 |
S1 |
p. e8-
1 p.
|
artikel
|
| 119 |
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis
|
Gabbia, D.
|
|
2015
|
47 |
S1 |
p. e42-
1 p.
|
artikel
|
| 120 |
THE AMPK RELATED KINASE NUAK2 INTERACTS WITH TGF-BETA AND REGULATES THE ACTIVATION PROCESS OF HEPATIC STELLATE CELLS (HSC)
|
Provenzano, A.
|
|
2015
|
47 |
S1 |
p. e23-
1 p.
|
artikel
|
| 121 |
The Cystic Fibrosis Conductance Regular (CFTR) controls c-Src tyrosine kinase signaling and regulates innate immunity and epithelial polarity in cholangiocytes
|
Fiorotto, R.
|
|
2015
|
47 |
S1 |
p. e2-
1 p.
|
artikel
|
| 122 |
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated cirrhosis: Results of a randomized controlled clinical trial
|
Piano, S.
|
|
2015
|
47 |
S1 |
p. e9-
1 p.
|
artikel
|
| 123 |
The first step for the prevention of ascites in patients with cirrhosis: the identification of an easily accessible predictor of the first onset of ascites
|
Piano, S.
|
|
2015
|
47 |
S1 |
p. e57-
1 p.
|
artikel
|
| 124 |
The Italian ENTAS cohort study: Entecavir effectiveness in naïve and treatment experienced patients with chronic hepatitis B
|
Porro, E.
|
|
2015
|
47 |
S1 |
p. e13-e14
nvt p.
|
artikel
|
| 125 |
THE ITA.LI.CA STAGING SYSTEM FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY
|
Farinati, F.
|
|
2015
|
47 |
S1 |
p. e23-
1 p.
|
artikel
|
| 126 |
The presence of white matter lesions is not associated with non-alcoholic fatty liver disease but with its histological severity
|
Petta, S.
|
|
2015
|
47 |
S1 |
p. e5-e6
nvt p.
|
artikel
|
| 127 |
The proto-oncogene tyrosine-protein kinase MER as a novel modulator of fibrogenesis in NAFLD
|
Di Maira, G.
|
|
2015
|
47 |
S1 |
p. e1-
1 p.
|
artikel
|
| 128 |
THE TM6SF2 E167K VARIANT IS AN INDEPENDENT PREDICTOR OF SEVERE LIVER STEATOSIS IN CHRONIC HEPATITIS C
|
Coppola, N.
|
|
2015
|
47 |
S1 |
p. e46-
1 p.
|
artikel
|
| 129 |
The two Thieno-triazolodiazepines WEB 2086 and WEB 2170 block Hepatocarcinoma progression by Hsp-dependent client kinoma protein ubiquitination
|
Ceni, E.
|
|
2015
|
47 |
S1 |
p. e47-
1 p.
|
artikel
|
| 130 |
The UK-PBC risk score: Derivation and validation of a risk score to predict liver events in the UK-PBC research cohort
|
Carbone, M.
|
|
2015
|
47 |
S1 |
p. e4-e5
nvt p.
|
artikel
|
| 131 |
THE USE OF A POCKET-SIZED ULTRASOUND DEVICE (PUD) IMPROVES PHYSICAL EXAMINATION: RESULTS OF AN IN- AND OUTPATIENT STUDY
|
Colli, A.
|
|
2015
|
47 |
S1 |
p. e35-e36
nvt p.
|
artikel
|
| 132 |
Total hepatitis B core antigen antibody, a quantitative non-invasive marker of hepatitis B virus induced liver disease
|
Moriconi, F.
|
|
2015
|
47 |
S1 |
p. e40-
1 p.
|
artikel
|
| 133 |
Transarterial Chemoocclusion (Taco) With Degradable-Starch-Microsphere In Unresecable Hepatocellular Carcinoma: A Prospective Pilot-Study
|
Francioso, S.
|
|
2015
|
47 |
S1 |
p. e32-
1 p.
|
artikel
|
| 134 |
Transient elastography in patients with chronic autoimmune hepatitis: is a good tool in evaluation of hepatic fibrosis?
|
Onali, S.
|
|
2015
|
47 |
S1 |
p. e64-
1 p.
|
artikel
|
| 135 |
Treatment of advanced hepatocellular carcinoma (HCC): a single centre cost analysis of yttrium 90 trans-arterial radio-embolization (TARE) versus Sorafenib
|
Lucà, M.G.
|
|
2015
|
47 |
S1 |
p. e45-
1 p.
|
artikel
|
| 136 |
UPDATED CUT OFF VALUES OF LIVER STIFFNESS TO MAXIMIZE TREATMENT OUTCOME OF INTERFERON FREE ANTI HCV REGIMENS
|
Colli, A.
|
|
2015
|
47 |
S1 |
p. e50-e51
nvt p.
|
artikel
|
| 137 |
Utility based criteria to select patients with hepatocellular carcinoma for liver transplantation: a multicentre cohort study
|
Vitale, A.
|
|
2015
|
47 |
S1 |
p. e43-
1 p.
|
artikel
|
| 138 |
Validation of a new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma in a European cohort
|
Gianstefani, A.
|
|
2015
|
47 |
S1 |
p. e6-e7
nvt p.
|
artikel
|
Tijdschrift beschrijving